Subarachnoid anaesthesia was induced in 40 patients with 0.5% bupivacaine 3 ml with no glucose, 5% glucose or 8% glucose, or with hyperbaric cinchocaine. The injections were made in the lateral position and the patients turned supine immediately. The onset, extent and duration of sensory and motor blockade, the quality of anaesthesia, cardiovascular effects, and the frequency of side-effects were studied. The hyperbaric solutions produced a greater cephalad spread (T6-T7) than the glucose-free solution (T10-T11). Cinchocaine produced a longer duration of action at Tl0 and Tl2 than the hyperbaric bupivacaine solutions. No advantage was seen when 8% rather than 5% glucose was used. The glucose-free bupivacaine produced intense blockade of long duration and was suitable when a lower level of blockade was adequate for the proposed surgery.
For several years there has been a shortage of local anaesthetic agents suitable for subarachnoid anaesthesia in the United Kingdom, and Ciba have threatened to withdraw cinchocaine (Nupercaine) on several occasions (Editorial, 1969) . Therefore, any new agent is welcome and should be evaluated carefully using a well-established local anaesthetic for comparison (Bonica, 1957) . Bupivacaine was introduced first in 1966, and used for subarachnoid blockade the same year (Ekblom and Widman, 1966) . However, few reports appeared until 1977, when a series of 5001 spinal anaesthetics using glucose-free bupivacaine was published (Nolte et al., 1977) . Hyperbaric bupivacaine has been suggested as a useful alternative (Goodison and Josyala, 1979) , but few reports of its use are available. The present study was undertaken to compare the anaesthesia produced by 0.5% bupivacaine in solutions of varying densities (from 0.997 to 1.021 at 37°C)with that produced by 0.5% cinchocaine in 6% glucose (density 1.024 at 37 °C) in awake patients in the supine horizontal position. As the methodology was similar to that used in several other studies of subarachnoid bupivacaine (Chambers, Edstrom and Scott, 1981; Axelssonet al., 1982; Chambers etal., 1982; Kalso, Tuominen and Rosenberg, 1982; Sinclair, Scott and Edstrom, 1982; Sundnes et al., 1982 ; Tuominen, Kalso and Rosenberg, 1982) , an opportunity of comparing the results was taken.
PATIENTS AND METHODS
Forty patients (32 male) aged 18-65 yr undergoing repair of an inguinal hernia, or orthopaedic surgery of the lower limb, under subarachnoid anaesthesia were studied. The study was explained to the patients and their consent obtained.
Papaveretum 0.3 nig kg" 1 to a maximum of 20mg, was given i.m. with hyoscine 0.06mgkg" 1 1 -2 h before the lumbar puncture. An i.v. infusion was established, the patient placed in the lateral position on a horizontal table, and lumbar puncture performed via the 13-4 space using a midline approach with a 25-or 22-gauge needle. The patients were allocated randomly to receive one of the following four test solutions: 0.5% cinchocaine in 6% glucose 1.5 ml, 0.5% glucose-free bupivacaine 3 ml, 0.5% bupivacaine with 5% glucose 3 ml and 0.5% bupivacaine with 8% glucose 3 ml (table I). The bupivacaine solutions were supplied in prepared ampoules using glucose monohydrate where appropriate. The cinchocaine (Nupercaine, Ciba) was supplied by the hospital pharmacy.
Once a free flow of clear cerebrospinal fluid was obtained, the test solution was injected at a rate of 1 ml/5 s without barbotage, the needle withdrawn and the patient turned supine immediately.
One investigator administered the solutions and another investigator, who was not, at any time, aware which solution had been given, evaluated the blockade. The cephalad and caudal spread of sensory blockade, the degree of motor blockade of the lower limbs, the arterial pressure (by oscillotonometry) and the heart rate were recorded every 2 min for 30 min after injection. The levels of sensory blockade were assessed using a Sherwood B4O0 27-gauge needle and recorded as anaesthesia (total loss of all sensation) and analgesia (loss of the sensation of pinprick, but touch retained). The degree of motor blockade was assessed on a 0-3 scale, 0 being no motor block, 1 being inability to raise the extended leg Oust able to move knees), 2 being inability to flex the knees (able to move feet only) and 3 being inability to flex the ankle joint (unable to move feet or knees) (Bromage, 1965) .
After 30 min, the patient was positioned and surgery commenced. The operating conditions and the need for any additional medication were recorded. Papaveretum was given to control pain, and 
RESULTS
There were no significant differences between the patients in the four groups in relation to age, weight, height, sex or needle size used.
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Time after injection (min) 0.5% Bupivacaine -0%glucose 0.5% Bupivacaine -52glucose 0.5% Bupivacaine -8% glucose 0.5% Cinchocaine -6% glucose Sensory block Onset (figs 1 and 2). The mean onset times for analgesia to a level of T12 were significantly shorter with the hyperbaric (2 min) than with the glucosefree solution (10 min) There were no differences in onset times between cinchocaine and the two hyperbaric bupivacaine solutions. The mean times until the spreads of analgesia and anaesthesia were maximal was around 10 min for all the hyperbaric solutions and around 15 min for the glucose-free solution.
FIG. 2. Onset of anaesthesia (meant SEM).
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FIG. 3. Segmental spread of analgesia (mean ± SEM).
Spread ( fig. 3 ; table II). The mean maximum spread of analgesia with all the hyperbaric solutions was significantly higher (T6-7) than was achieved with the glucose-free bupivacaine (T10-11). The differences in spread between patients given the hyperbaric solutions and those given the glucosefree solution were statistically significant from 10 to 90 min after injection. There were no differences between cinchocaine and the hyperbaric solutions of bupivacaine. Table II illustrates the scatter of levels of analgesia at 30 min. There was one abnormally low level in the cinchocaine group (LI) and one abnormally high block in the isobaric bupivacaine group (T4). The levels of analgesia were consistently 2-3 segments more than the level of anaesthesia. (fig. 4) . After the higher cephalad spread of blockade with the hyperbaric solutions, the duration of analgesia in the thoracic segments was relatively longer and in the lumbar segments shorter than that obtained with the glucose-free solution. A significantly shorter duration of action was recorded with the hyperbaric than with the glucose-free bupivacaine solution at the S1-L2 levels. At the T12 level, cinchocaine had significantly longer duration than all the bupivacaine solutions (185 min v. 125 min) and at L2, a longer duration than that of the bupivacaine solutions with glucose.
Duration
Motor block
Onset ( fig. 5 ). The onset of complete motor blockade of the lower limbs was significantly more rapid for the bupivacaine solutions containing 5% and 8% glucose compared with the glucose-free bupivacaine solution. No differences were found between cinchocaine and hyperbaric bupivacaine solutions. The mean time for complete motor block was 5-10 min for the hyperbaric solutions and around 15 min for the glucose-free solution. 0.5% Bupivacaine-0% glucose 05% Bupivacaine -5% glucose 0.5% Bupivacaine-8°. glucose 0.5% Cinchocaine-6% glucose
Fio. 4. Duration of analgesia (mean ± SEM).
Degree (table III) . There were no significant differences in the degrees of motor blockade between the groups, or in the number of each group reaching motor block 3. (fig. 6 ). The mean duration of motor blockade was shorter with the hyperbaric bupivacaine solutions (160min) compared with the glucose-free bupivacaine solution (240 min), and the cinchocaine solution (225 min). Significantly longer durations were found for most degrees of motor blockade with the glucose-free solution compared with the bupivacaine solutions containing 5% and 8% glucose. (table IV) A total of five patients received supplementary analgesia with papaveretum. All five were fit, young males (age range 18-45 yr) undergoing surgery on the knee joint and received papaveretum 20 mg i.v. The two patients in the cinchocaine group received the papaveretum 60-90 min after administration of the block, on experiencing discomfort as the blockade at the operation site regressed from anaesthesia to analgesia only, while the upper level of analgesia analgesia 135 min after institution of the block because of complete regression of analgesia. In all patients the operative procedure was completed without the need for general anaesthesia. (table V) Bradycardia (heart rate less than 50 beat min" 1 ) was treated with atropine O.Smg i.v. in seven patients and hypotension (arterial pressure less than 90 mm Hg systolic) was treated by the rapid infusion of 250-500 ml of lactated Ringer's solution or ephedrine 15mg i.v. Taking these treatments into account, systolic pressure decreased by about 10-15% and heart rate by about 5-15% in all four groups. No atropine was required in the glucosefree group while two or three patients in each of the hyperbaric groups received atropine. One patient Previous studies had suggested 3 ml as a suitable volume of subarachnoid bupivacaine (Nolte et al., 1977) . Heavy cinchocaine 1.5 ml was chosen as it was approximately in the middle of the normal dose range for this agent and it was decided not to dilute the standard pharmaceutical preparation (Nupercaine Ciba) to an equivalent volume. McClure, Brown and Wildsmith (1982) had found that the administration of the same dose of local anaesthetic in different isobaric volumes had produced no difference in the mean height of blockade, but that the height and quality of the block were more variable with large volumes. It would have been expected that the 3 ml of isobaric bupivacaine would be less predictable than the cinchocaine. However, as there was one abnormally high block (T4) with isobaric bupivacaine and one abnormally low block (LI) with cinchocaine, the range of values was about the same.
Duration
Quality of anaesthesia
Cardiovascular changes
It was felt that useful information might be obtained by using hyperbaric bupivacaine with two different glucose concentrations (5% and 8%) to see whether we could confirm or refute a previous report that bupivacaine with 8% glucose produced smaller deviations around the mean than bupivacaine with 5% glucose (Chambers, Edstrom and Scott, 1981) . Another author has reported problems in controlling the spread of blockade if the glucose concentration is too high (Eckstein, Vicente-Eckstein and Steiner, 1978) . No significant advantage of 8% over 5% glucose could be found, although the 8% solution did spread slightly higher. This study has confirmed the different behaviour of the glucose-free solution of bupivacaine compared with that of the hyperbaric solutions. The level of sensory blockade reached by the glucosefrfce solution was significantly lower (T10-11) than the hyperbaric solutions (T6-7), rendering the glucose-free solution unsuitable for abdominal surgery in the volume and posture used. As a result of low cephalad spread of anaesthesia, two patients in the glucose-free bupivacaine group required supplementary analgesia before surgery could commence.
A previous study reported poor predictability and wide variability in the spread of glucose-free bupivacaine (Cameron et al., 1981) , and in this study one patient had analgesia to T4 and anaesthesia to T6 using 3 ml of glucose-free bupivacaine. However, generally, the cephalad spread was limited and the glucose-free bupivacaine produced intense sensory and motor block of long duration which was suitable for surgery of the lower limbs or perineum. Our results with glucose-free bupivacaine are comparable to those obtained with isobaric amethocaine (Wildsmith et al., 1981) . Another possible advantage of glucose-free solution is the ability to position patients with painful conditions such as fractured neck of femur with the painful side uppermost, and to be able to re-position them painlessly for operation within a few minutes (Tattersall, 1983) .
The introduction of hyperbaric 0.5%bupivacaine would be welcomed (Chambers, 1982) , and useful information was provided by comparing hyperbaric 0.5% bupivacaine solutions with heavy cinchocaine, the most popular hyperbaric agent in the United Kingdom. There were few differences between hyperbaric bupivacaine and cinchocaine in the volumes used, although cinchocaine showed a significantly longer duration of analgesia (around 2 h at T10 and 3h at T12) than hyperbaric bupivacaine (around 1.5h at T10 and 2h at T12). However, an increase in the volume of 0.5% bupivacaine with 8% glucose can prolong the duration of analgesia so that 4 ml produces a duration of analgesia of 2.5 h at T12 (Axelssonetal.,1982) .
Decreases in arterial pressure and heart rate were small, and showed no significant differences between the groups.
Glucose-free 0.5% bupivacaine 3 ml is unsuitable for abdominal surgery, but seems satisfactory for surgery of the lower limbs. Hyperbaric 0.5% bupivacaine 3 ml with either 5% or 8% glucose proved to be useful for subarachnoid anaesthesia and comparable to 0.5% cinchocaine 1.5 ml with 6% glucose. While hyperbaric bupivacaine showed no clear advantages over cinchocaine, it can be seen as an alternative if a slightly shorter duration of analgesia is required.
Chez 40 patients, une r»rhiatw«th>«if a ete pratiquee avec de la bupivacaine 0,5%, 3 ml, sans glucose ou avec du glucose a 5% ou a 8%, ou avec de la cinchocaine hyperbare. Let BLOQUEO SUB-ARACNOIDEO CON BUPIVACAINA Una comparacion con cinchocaina
SUMARIO
Se indujo una anestesia sub-aracnotdea en 40 pacientes con 3 ml de bupivacaina al 0,5% sin glucosa, con 5% de glucosa o con 8% de glucosa, o con cinchocaina hiperbarics. Se llevaron a cabo las inyecciones en posicion lateral y se dieron vuelta a los pacientes en posicion supina de inmediato. El prindpio, el grado y la duration del bloqueo motor y sensor, la calidad de la anestesia, los efectos cardiovasculares y la frecuencia de los efectos secundarios fueron objeto de estudios. Las soluciones hiperbaricas produjeron una cefalica mayor (T6-T7) que la de la solucion sin glucosa (T10-T11). La cinchocaina produjo una miyor duracion de la acci6n en T10 y T12 que la de las soluciones de bupivacaina hiperbaricas. No se observo ningiina ventaja al usar un 8% de glucosa mas bkn que un 5%. La bupivacaina sin glucosa produjo un bloqueo intenso de larga duraci6n y convenia cuando era apropiado un nivel mis bajo de bloqueo para la drujia contemplada.
